CSIMarket
 


Pro dex Inc   (PDEX)
Other Ticker:  
 
 

Pro Dex Inc Accounts Receivables Turnover Ratio from the second quarter 2024 to the second quarter 2023

Quarterly Results, Trends, Rankings, Statistics


Pro Dex Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2024 to a ratio of 4.32, above the company average. This is a clear sign of healthy business climate in the Medical Equipment & Supplies industry and improving liquidity at their respective customers, during the second quarter 2024. Average receivable collection period, for the Pro Dex Inc in Dec 31 2023 quarter, has decreased to 84 days, compared to 85 days, in the Sep 30 2023 quarter.

If we take a look into Healthcare sector 51 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 661, from overall ranking in the first quarter 2024 at 2719.

What is Receivable Turnover Ratio?
What is Pro Dex Inc Selling?


What is Receivable Turnover Ratio?




PDEX Receivables Turnover Ratio (Dec 31 2023)
II. Quarter
(Sep 30 2023)
I. Quarter
(Jun 30 2023)
IV. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
II. Quarter
Y / Y Receivable Change 7.99 % -0.1 % -35.31 % 21.72 % 37.8 %
Y / Y Revenue Change 11.58 % 7.68 % -15.66 % 41.17 % 10.9 %
Receivable Turnover Ratio (TTM) 4.32 4.29 4.21 3.91 3.74
PDEX's Total Ranking # 661 # 2719 # 2936 # 2878 # 299
Average receivable collection period 85 85 87 93 98
Seq. Receivable Change 19.35 % 10.87 % -5.8 % -13.37 % 10.41 %
Seq. Revenue Change 5.44 % 12.21 % -18.66 % 15.93 % 1.76 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 25
Healthcare Sector # 52
Overall Market # 661

Receivable Turnover Ratio Statistics
High Average Low
1.84 1.17 0.92
(Sep 30 2016)   (Mar 31 2022)






Financial Statements
Pro Dex Inc 's Accounts Receivable $ 13 Millions Visit PDEX's Balance sheet
Pro Dex Inc 's Sales TTM $ 48 Millions Visit PDEX's Income Statement
Where are PDEX's Sales coming from? Visit PDEX's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PDEX's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover
Accounts Receivable Turnover for PDEX's Competitors
Receivables Turnover Ratio for PDEX's Suppliers
Accounts Receivables Turnover Ratio for PDEX's Customers

You may also want to know
PDEX's Growth Rates PDEX's Roa PDEX's Inventory Turnover Ratio PDEX's Dividend Comparisons
PDEX's Profitability Ratios PDEX's Roi PDEX's Asset Turnover Ratio PDEX's Dividend Growth
PDEX's Valuation Ratios PDEX's Roe PDEX's Financial Strength Ratios PDEX's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2023, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2023 Receivable at quarter ending Dec 31 2023
Lumos Pharma Inc   10.07 $ 2.051  Millions$ 0.204  Millions
Semler Scientific Inc   9.93 $ 68.184  Millions$ 6.867  Millions
United Therapeutics Corporation  9.85 $ 2,327.500  Millions$ 236.175  Millions
Xoma Corporation  9.74 $ 4.758  Millions$ 0.489  Millions
Eton Pharmaceuticals Inc   9.66 $ 31.061  Millions$ 3.216  Millions
Procyon Corporation  9.64 $ 4.700  Millions$ 0.488  Millions
Innovative Eyewear Inc   9.62 $ 1.152  Millions$ 0.120  Millions
The Pennant Group Inc   9.54 $ 544.891  Millions$ 57.095  Millions
Voyager Therapeutics Inc   9.51 $ 250.008  Millions$ 26.288  Millions
Irhythm Technologies Inc   9.27 $ 491.806  Millions$ 53.054  Millions
Lipella Pharmaceuticals Inc   9.11 $ 0.450  Millions$ 0.049  Millions
Harmony Biosciences Holdings inc   9.03 $ 581.786  Millions$ 64.448  Millions
Catalyst Pharmaceuticals Inc   8.96 $ 398.204  Millions$ 44.440  Millions
Fresenius Medical Care Ag  8.93 $ 21,788.051  Millions$ 2,440.676  Millions
Insmed Inc  8.84 $ 305.528  Millions$ 34.560  Millions
Inspire Medical Systems inc   8.77 $ 624.223  Millions$ 71.153  Millions
Encompass Health Corporation  8.75 $ 4,801.200  Millions$ 548.575  Millions
Igc Pharma Inc   8.66 $ 1.215  Millions$ 0.140  Millions
Adapthealth Corp   8.66 $ 3,200.177  Millions$ 369.646  Millions
Clearpoint Neuro Inc   8.62 $ 23.955  Millions$ 2.778  Millions
Veracyte inc   8.62 $ 361.051  Millions$ 41.882  Millions
Ngm Biopharmaceuticals Inc   8.61 $ 4.417  Millions$ 0.513  Millions
Adma Biologics Inc   8.46 $ 257.942  Millions$ 30.497  Millions
Astrazeneca Plc  8.45 $ 45,811.000  Millions$ 5,424.000  Millions
Inmode Ltd   8.39 $ 492.048  Millions$ 58.630  Millions
Capricor Therapeutics inc   8.38 $ 25.178  Millions$ 3.004  Millions
Insulet Corporation  8.33 $ 1,697.100  Millions$ 203.850  Millions
Ati Physical Therapy Inc   8.31 $ 699.016  Millions$ 84.118  Millions
Cadre Holdings Inc   8.28 $ 481.726  Millions$ 58.172  Millions
Nephros Inc   8.28 $ 13.405  Millions$ 1.620  Millions

Date modified: 2024-02-08T22:47:41+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com